126 related articles for article (PubMed ID: 35489774)
1. Early Metabolic Changes in 1H-MRSI Predictive for Survival in Patients With Newly Diagnosed High-grade Glioma.
Wang MH; Roa W; Wachowicz K; Yahya A; Murtha A; Amanie J; Chainey J; Quon H; Ghosh S; Patel S
Anticancer Res; 2022 May; 42(5):2665-2673. PubMed ID: 35489774
[TBL] [Abstract][Full Text] [Related]
2. Serial analysis of 3D H-1 MRSI for patients with newly diagnosed GBM treated with combination therapy that includes bevacizumab.
Nelson SJ; Li Y; Lupo JM; Olson M; Crane JC; Molinaro A; Roy R; Clarke J; Butowski N; Prados M; Cha S; Chang SM
J Neurooncol; 2016 Oct; 130(1):171-179. PubMed ID: 27535746
[TBL] [Abstract][Full Text] [Related]
3. Association of early changes in 1H MRSI parameters with survival for patients with newly diagnosed glioblastoma receiving a multimodality treatment regimen.
Nelson SJ; Kadambi AK; Park I; Li Y; Crane J; Olson M; Molinaro A; Roy R; Butowski N; Cha S; Chang S
Neuro Oncol; 2017 Mar; 19(3):430-439. PubMed ID: 27576874
[TBL] [Abstract][Full Text] [Related]
4. 3-Dimensional magnetic resonance spectroscopic imaging at 3 Tesla for early response assessment of glioblastoma patients during external beam radiation therapy.
Muruganandham M; Clerkin PP; Smith BJ; Anderson CM; Morris A; Capizzano AA; Magnotta V; McGuire SM; Smith MC; Bayouth JE; Buatti JM
Int J Radiat Oncol Biol Phys; 2014 Sep; 90(1):181-9. PubMed ID: 24986746
[TBL] [Abstract][Full Text] [Related]
5. Longitudinal multivoxel MR spectroscopy study of pediatric diffuse brainstem gliomas treated with radiotherapy.
Laprie A; Pirzkall A; Haas-Kogan DA; Cha S; Banerjee A; Le TP; Lu Y; Nelson S; McKnight TR
Int J Radiat Oncol Biol Phys; 2005 May; 62(1):20-31. PubMed ID: 15850898
[TBL] [Abstract][Full Text] [Related]
6. Multisection 1H magnetic resonance spectroscopic imaging assessment of glioma response to chemotherapy.
Balmaceda C; Critchell D; Mao X; Cheung K; Pannullo S; DeLaPaz RL; Shungu DC
J Neurooncol; 2006 Jan; 76(2):185-91. PubMed ID: 16151595
[TBL] [Abstract][Full Text] [Related]
7. Identification of MRI and 1H MRSI parameters that may predict survival for patients with malignant gliomas.
Li X; Jin H; Lu Y; Oh J; Chang S; Nelson SJ
NMR Biomed; 2004 Feb; 17(1):10-20. PubMed ID: 15011246
[TBL] [Abstract][Full Text] [Related]
8. (1)H MRSI and progression-free survival in patients with WHO grades II and III gliomas.
Hattingen E; Delic O; Franz K; Pilatus U; Raab P; Lanfermann H; Gerlach R
Neurol Res; 2010 Jul; 32(6):593-602. PubMed ID: 19726017
[TBL] [Abstract][Full Text] [Related]
9. Prospective serial proton MR spectroscopic assessment of response to tamoxifen for recurrent malignant glioma.
Sankar T; Caramanos Z; Assina R; Villemure JG; Leblanc R; Langleben A; Arnold DL; Preul MC
J Neurooncol; 2008 Oct; 90(1):63-76. PubMed ID: 18600428
[TBL] [Abstract][Full Text] [Related]
10. Measurements of diagnostic examination performance using quantitative apparent diffusion coefficient and proton MR spectroscopic imaging in the preoperative evaluation of tumor grade in cerebral gliomas.
Server A; Kulle B; Gadmar ØB; Josefsen R; Kumar T; Nakstad PH
Eur J Radiol; 2011 Nov; 80(2):462-70. PubMed ID: 20708868
[TBL] [Abstract][Full Text] [Related]
11. ACRIN 6684: Multicenter, phase II assessment of tumor hypoxia in newly diagnosed glioblastoma using magnetic resonance spectroscopy.
Ratai EM; Zhang Z; Fink J; Muzi M; Hanna L; Greco E; Richards T; Kim D; Andronesi OC; Mintz A; Kostakoglu L; Prah M; Ellingson B; Schmainda K; Sorensen G; Barboriak D; Mankoff D; Gerstner ER;
PLoS One; 2018; 13(6):e0198548. PubMed ID: 29902200
[TBL] [Abstract][Full Text] [Related]
12. Proton magnetic resonance spectroscopy in immunocompetent patients with primary central nervous system lymphoma.
Raizer JJ; Koutcher JA; Abrey LE; Panageas KS; DeAngelis LM; Lis E; Xu S; Zakian KL
J Neurooncol; 2005 Jan; 71(2):173-80. PubMed ID: 15690135
[TBL] [Abstract][Full Text] [Related]
13. [Metabolic imaging to follow stereotactic radiation of gliomas -- the role of 1H MR spectroscopy in comparison to FDG-PET and IMT-SPECT].
Lichy MP; Henze M; Plathow C; Bachert P; Kauczor HU; Schlemmer HP
Rofo; 2004 Aug; 176(8):1114-21. PubMed ID: 15346287
[TBL] [Abstract][Full Text] [Related]
14. Prognostic value of choline and creatine in WHO grade II gliomas.
Hattingen E; Raab P; Franz K; Lanfermann H; Setzer M; Gerlach R; Zanella FE; Pilatus U
Neuroradiology; 2008 Sep; 50(9):759-67. PubMed ID: 18523762
[TBL] [Abstract][Full Text] [Related]
15. Single- and multivoxel proton spectroscopy in pediatric patients with diffuse intrinsic pontine glioma.
Steffen-Smith EA; Venzon DJ; Bent RS; Hipp SJ; Warren KE
Int J Radiat Oncol Biol Phys; 2012 Nov; 84(3):774-9. PubMed ID: 22445531
[TBL] [Abstract][Full Text] [Related]
16. The Association between Whole-Brain MR Spectroscopy and IDH Mutation Status in Gliomas.
Goryawala M; Saraf-Lavi E; Nagornaya N; Heros D; Komotar R; Maudsley AA
J Neuroimaging; 2020 Jan; 30(1):58-64. PubMed ID: 31868291
[TBL] [Abstract][Full Text] [Related]
17. Glioma grading: sensitivity, specificity, and predictive values of perfusion MR imaging and proton MR spectroscopic imaging compared with conventional MR imaging.
Law M; Yang S; Wang H; Babb JS; Johnson G; Cha S; Knopp EA; Zagzag D
AJNR Am J Neuroradiol; 2003; 24(10):1989-98. PubMed ID: 14625221
[TBL] [Abstract][Full Text] [Related]
18. Magnetic resonance spectroscopic imaging for visualization of the infiltration zone of glioma.
Stadlbauer A; Buchfelder M; Doelken MT; Hammen T; Ganslandt O
Cent Eur Neurosurg; 2011 May; 72(2):63-9. PubMed ID: 20635312
[TBL] [Abstract][Full Text] [Related]
19. Magnetic resonance spectroscopy imaging in radiotherapy planning for recurrent glioma.
Ballangrud AM; Lymberis S; Thakur SB; Karimi S; Huang W; Abrey LE; Beal K; Iwamoto FM; Brennan C; Gutin PH; Chang J
Med Phys; 2011 May; 38(5):2724-30. PubMed ID: 21776809
[TBL] [Abstract][Full Text] [Related]
20. Prognostic significance of serial magnetic resonance spectroscopies over the course of radiation therapy for patients with malignant glioma.
Alexander A; Murtha A; Abdulkarim B; Mehta V; Wheatley M; Murray B; Riauka T; Hanson J; Fulton D; McEwan A; Roa W
Clin Invest Med; 2006 Oct; 29(5):301-11. PubMed ID: 17144440
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]